Improving enrollment in clinical trials for adolescents with cancer

Peter H. Shaw, Brandon Hayes-Lattin, Rebecca Johnson, Archie Bleyer

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Overall cancer cure rates have risen over the last 30 years. Adolescent and young adult (AYA) oncology patients aged 15 to 39 have not shared in these successes as an age group, including those who fall into the younger age group of 15 to 19 years. The reasons for this deficit in survival improvement are manifold, but research has shown that an important factor is decreased enrollment in therapeutic clinical trials in this population versus younger patients. The paucity of adolescents treated in clinical trials is itself the result of several elements of the health care landscape in the United States. On the local level, these factors include referral patterns and facilities available; on the national level, related factors include the number of clinical trials available for this age group and health care provider education in the care of these patients. We examine the data available that have contributed to this deficit in the United States and offer broad strategies to address these shortcomings with the goal of improving outcomes in this underserved population.

Original languageEnglish (US)
JournalPediatrics
Volume133
Issue numberSUPPL. 3
DOIs
StatePublished - Jun 1 2014

Fingerprint

Age Groups
Clinical Trials
Neoplasms
Vulnerable Populations
Health Personnel
Young Adult
Patient Care
Referral and Consultation
Delivery of Health Care
Education
Survival
Research
Population
Cancer
Enrollment
Healthcare
Therapeutics
Young Adults
Oncology

Keywords

  • AYA oncology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Arts and Humanities (miscellaneous)

Cite this

Improving enrollment in clinical trials for adolescents with cancer. / Shaw, Peter H.; Hayes-Lattin, Brandon; Johnson, Rebecca; Bleyer, Archie.

In: Pediatrics, Vol. 133, No. SUPPL. 3, 01.06.2014.

Research output: Contribution to journalArticle

Shaw, Peter H. ; Hayes-Lattin, Brandon ; Johnson, Rebecca ; Bleyer, Archie. / Improving enrollment in clinical trials for adolescents with cancer. In: Pediatrics. 2014 ; Vol. 133, No. SUPPL. 3.
@article{9e2dceb427884361841f2cada244b77b,
title = "Improving enrollment in clinical trials for adolescents with cancer",
abstract = "Overall cancer cure rates have risen over the last 30 years. Adolescent and young adult (AYA) oncology patients aged 15 to 39 have not shared in these successes as an age group, including those who fall into the younger age group of 15 to 19 years. The reasons for this deficit in survival improvement are manifold, but research has shown that an important factor is decreased enrollment in therapeutic clinical trials in this population versus younger patients. The paucity of adolescents treated in clinical trials is itself the result of several elements of the health care landscape in the United States. On the local level, these factors include referral patterns and facilities available; on the national level, related factors include the number of clinical trials available for this age group and health care provider education in the care of these patients. We examine the data available that have contributed to this deficit in the United States and offer broad strategies to address these shortcomings with the goal of improving outcomes in this underserved population.",
keywords = "AYA oncology",
author = "Shaw, {Peter H.} and Brandon Hayes-Lattin and Rebecca Johnson and Archie Bleyer",
year = "2014",
month = "6",
day = "1",
doi = "10.1542/peds.2014-0122F",
language = "English (US)",
volume = "133",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Improving enrollment in clinical trials for adolescents with cancer

AU - Shaw, Peter H.

AU - Hayes-Lattin, Brandon

AU - Johnson, Rebecca

AU - Bleyer, Archie

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Overall cancer cure rates have risen over the last 30 years. Adolescent and young adult (AYA) oncology patients aged 15 to 39 have not shared in these successes as an age group, including those who fall into the younger age group of 15 to 19 years. The reasons for this deficit in survival improvement are manifold, but research has shown that an important factor is decreased enrollment in therapeutic clinical trials in this population versus younger patients. The paucity of adolescents treated in clinical trials is itself the result of several elements of the health care landscape in the United States. On the local level, these factors include referral patterns and facilities available; on the national level, related factors include the number of clinical trials available for this age group and health care provider education in the care of these patients. We examine the data available that have contributed to this deficit in the United States and offer broad strategies to address these shortcomings with the goal of improving outcomes in this underserved population.

AB - Overall cancer cure rates have risen over the last 30 years. Adolescent and young adult (AYA) oncology patients aged 15 to 39 have not shared in these successes as an age group, including those who fall into the younger age group of 15 to 19 years. The reasons for this deficit in survival improvement are manifold, but research has shown that an important factor is decreased enrollment in therapeutic clinical trials in this population versus younger patients. The paucity of adolescents treated in clinical trials is itself the result of several elements of the health care landscape in the United States. On the local level, these factors include referral patterns and facilities available; on the national level, related factors include the number of clinical trials available for this age group and health care provider education in the care of these patients. We examine the data available that have contributed to this deficit in the United States and offer broad strategies to address these shortcomings with the goal of improving outcomes in this underserved population.

KW - AYA oncology

UR - http://www.scopus.com/inward/record.url?scp=84901804152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901804152&partnerID=8YFLogxK

U2 - 10.1542/peds.2014-0122F

DO - 10.1542/peds.2014-0122F

M3 - Article

VL - 133

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - SUPPL. 3

ER -